AstraZeneca vaccine benefits increase with age: EMA

The EU’s drug watchdog said Friday that a review of AstraZeneca’s COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.